Research Article

Related GMR Articles

06/03/2016
Breast cancer; Chinese population; Polymorphism; XPG

We conducted a case-control study to investigate the role of XPG gene polymorphisms (rs2094258, rs751402, and rs17655) in the development of breast cancer. Patients with breast cancer (320) and control subjects (294) were consecutively selected from the Zhongshan Hospital between April 2013 and January 2015. The genotyping of XPG rs2094258, rs751402, and rs17655 was performed using ... more

S.H. Ma; F.H. Ling; Y.X. Sun; S.F. Chen; Z. Li; S.H. Ma; F.H. Ling; Y.X. Sun; S.F. Chen; Z. Li
05/20/2016
Breast cancer; Proliferation; Resveratrol; Tristetraprolin

Resveratrol is a natural compound that exhibits anticancer properties. Previous studies have proved that it can inhibit the proliferation of breast cancer cell lines and upregulate some cytokines such as cyclooxygenase-2 (COX-2) and vascular endothelial growth factor (VEGF). The initiation and progression of cancer are associated with the abnormal expression of multiple cytokines. ... more

C. Li; C. Tang; G. He; C. Li; C. Tang; G. He
05/13/2016
Association analysis; Breast cancer; Genetic variants; Haplotype; Hormone-related gene

Sex hormones play important roles in breast cancer (BC) development. This study investigated associations between BC risk and hormone-related gene variants in Chinese women. In a cohort of 336 patients with histopathologically confirmed BC and 390 age-matched controls, we genotyped seven single nucleotide polymorphisms (SNPs) in five hormone-related genes: estrogen receptor-α (ESR1 ... more

Z. Pan; Z. Fu; Q. Song; W. Cao; W. Cheng; X. Xu; Z. Pan; Z. Fu; Q. Song; W. Cao; W. Cheng; X. Xu
05/12/2016
Breast cancer; Keap1; Prognosis

Our objective was to explore the expression and clinical significance of Kelch-like epichlorohydrin-associated protein 1 (Keap1) in breast cancer tissue. Eighty-one breast cancer patients having undergone surgical treatment in our hospital between March 2002 and December 2008 were enrolled in this study. Normal tissue adjacent to tumors was used for the control samples. Diagnoses for all ... more

L. Zhang; W.P. Yang; L.Y. Wu; X. Zhu; C.Y. Wei; L. Zhang; W.P. Yang; L.Y. Wu; X. Zhu; C.Y. Wei
06/03/2016
Genetic polymorphism; Interleukin-10 Serum lipoprotein

Previous studies have shown that cytokines can affect serum lipoprotein concentrations. The aim of this study was to examine the association between IL-10 gene polymorphisms and serum lipoprotein levels of Han Chinese individuals. A total of 359 Han Chinese people were enrolled in this investigation. IL-10 -592, -819, and -1082 genotypes were established using polymerase ... more

W.Q. Yang; W.Q. Yang
06/03/2016
Arctic fox; Genetic polymorphism; Microsatellite marker

The blue fox, belonging to the family Canidae, is a coat color variant of the native arctic fox (Alopex lagopus). To date, microsatellite loci in blue fox are typically amplified using canine simple sequence repeat primers. In the present study, we constructed an (AC)n enrichment library, and isolated and identified 17 polymorphic microsatellite markers for blue fox. ... more

Y.M. Li; P.C. Guo; J.Y. Lu; C.Y. Bai; Z.H. Zhao; S.Q. Yan; Y.M. Li; P.C. Guo; J.Y. Lu; C.Y. Bai; Z.H. Zhao; S.Q. Yan
04/04/2016
Breast cancer; Meta-analysis; MicroRNA-10b; Prognostic factor

Many microRNAs (miRNAs) exhibit altered expression levels in cancers, and they may be considered as valuable prognostic biomarkers for cancers. Here we aimed to summarize the recent advances in miR-10b involvement in human breast cancer and analyze the predicting role of miR-10b for survival. We searched, Embase, and Wanfang databases to identify studies on the prognostic role of miR-10b ... more

N. Wang; P. Chen; L.P. Huang; T.Z. Wang; N. Wang; P. Chen; L.P. Huang; T.Z. Wang; N. Wang; P. Chen; L.P. Huang; T.Z. Wang
04/04/2016
Biomarker; Breast cancer; Histological subtypes; Proteomics

Breast cancer is the second most common cancer worldwide and the first among women. Invasive ductal carcinoma (IDC) and invasive lobular carcinoma (ILC) are the two major histological subtypes, and the clinical and molecular differences between them justify the search for new markers to distinguish them. As proteomic analysis allows for a powerful and analytical approach to identify ... more

N.C.S. Oliveira; T.H.B. Gomig; H.H. Milioli; F. Cordeiro; G.G. Costa; C.A. Urban; R.S. Lima; I.J. Cavalli; E.M.S.F. Ribeiro; N.C.S. Oliveira; T.H.B. Gomig; H.H. Milioli; F. Cordeiro; G.G. Costa; C.A. Urban; R.S. Lima; I.J. Cavalli; E.M.S.F. Ribeiro; N.C.S. Oliveira; T.H.B. Gomig; H.H. Milioli; F. Cordeiro; G.G. Costa; C.A. Urban; R.S. Lima; I.J. Cavalli; E.M.S.F. Ribeiro
07/14/2016
Breast cancer; DNA methylation; Gene promoter; RASSFIA gene
Y. Ji; H.H. Jin; M.D. Wang; W.X. Cao; J.L. Bao; Y. Ji; H.H. Jin; M.D. Wang; W.X. Cao; J.L. Bao; Y. Ji; H.H. Jin; M.D. Wang; W.X. Cao; J.L. Bao
07/14/2016
Breast cancer; Co-expression network; Eribulin; Hub genes; Paclitaxel; Pathway-enrichment analysis

We investigated the effects of eribulin and paclitaxel on breast cancer (BC) by exploring molecular biomarkers and pathways. Co-expression networks were constructed by differentially co-expressed genes and links, and centralities were analyzed to explore the hub genes. Pathway-enrichment analysis was performed. The hub genes were validated using the polymerase chain reaction and western ... more

J. Qin; Y.H. Chen; J. Qin; Y.H. Chen

Pages